21 results
8-K
EX-99.2
AUPH
Aurinia Pharmaceuticals Inc
5 Apr 23
Aurinia Pharmaceuticals Announces Promising Topline Data from Renal Biopsy Sub-study of the AURORA Trial
8:16am
with hyperglycemia, diabetes and islet cells death. In studies of lupus nephritis, LUPKYNIS has not had such associations5 1. van Gelder T et al. Expert Rev Clin
8-K
EX-99.1
y5wn6u
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
DEF 14A
6dok3
10 May 21
Definitive proxy
4:06pm
PRE 14A
jdg5a3t32 agkol
27 Apr 21
Preliminary proxy
4:32pm
10-K
EX-10.6
l91w85cj36wy1 qy
24 Feb 21
Annual report
4:09pm
10-K
bldo j5s2pr
24 Feb 21
Annual report
4:09pm
6-K
EX-99.2
eaobb6 p8
30 Dec 20
Material Change Report
5:30pm
40-F
EX-99.1
kevce6
5 Mar 20
Annual report (Canada)
4:06pm
40-F
c69folzj7
5 Mar 20
Annual report (Canada)
4:06pm
40-F
EX-99.1
8cnusbc
19 Mar 19
Annual report (Canada)
4:16pm
40-F
sm20ci3dyd8dts4iw
19 Mar 19
Annual report (Canada)
4:16pm
6-K
EX-99.1
7907zsp9wik
21 Oct 14
Aurinia Pharmaceuticals to Host Lupus Opinion Leader Meeting and Webcast on October 23 in New York City
12:00am
40FR12B/A
EX-99.16
bioj5y69k0d3a mzird
19 Jun 14
Initial registration of securities (Canada) (amended)
12:00am